Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,265 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pre-Screening Clear all

Conditions: Lymphoma, Myeloma, Cytokine Release Syndrome, Immune Effector Cell Associated Neurotoxicity Syndrome
Interventions: Home Automated Telemanagement (HAT) Patient Unit; Device
Lead sponsor: University of Utah; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hypertension, Vascular Diseases, Cardiovascular Diseases
Interventions: Renal Denervation using the Symplicity Renal Denervation System, Sham Renal Denervation, Renal Angiography; Device · Other
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 3
States / cities: Atlanta, Georgia • Durham, North Carolina • Charleston, South Carolina

Conditions: Regional Anesthesia
Interventions: tool developed using cameras and a computer; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 25 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Lung Cancer, Smoking Cessation
Interventions: Patient decision aid; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Wrinkle
Interventions: Fraxel Laser Treatment; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pedal Fat Pad Atrophy
Interventions: Pedal Fat Grafting, Local anesthetic; Procedure · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Colonoscopy
Interventions: Miralax (PEG 3350), Amitiza (Lubiprostone), Dulcolax (Bisacodyl), Golytely (polyethylene glycol); Drug
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 425 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Colorectal Cancer (CRC) Screening, CRC Screening, Rectal Cancer, Colon Cancer, Colorectal Cancer
Interventions: Colorectal Cancer Education Materials, Cologuard test kit, Fecal immunochemical test kit, Usual Care; Behavioral · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 45 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Peripheral Artery Disease, Amputation, Smoking, Diabetes, Hypercholesterolemia, Hypertension
Interventions: ABI using QuantaFlo™; Device
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 238 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Major Depressive Disorder
Interventions: Ketamine, Psychotherapy; Drug · Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Post Concussive Syndrome
Interventions: Hyperbaric Oxygen Therapy; Drug
Lead sponsor: Summit Hyperbarics and Wellness; Other
Eligibility: 18 Years to 75 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boise, Idaho

Conditions: Colonoscopy
Interventions: colonoscopy; Procedure
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 18 Years to 80 Years
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Parkinson's Disease, Tourette's Syndrome, Tic Disorders, Dystonia, Movement Disorders
Interventions: Transcranial Direct Current Stimulation (tDCS), Eye-tracking Device, Pulsed vibrator, Gait Trainer Treadmill (GTT), Standard psychiatric scales SCID-I, YBOCS and SCI-OBS-lifetime and cognitive scales MMSE and MOCA, iMobility, QMAT, Treadmill Test, Arm Intellistretch Device, Transcranial Sonography (TCS), Behavioral tasks, TMS single/paired pulse, MEG, EEG, MRI techniques, Peripheral Nerve Stimulation, EMG, Trancutaneous spinal direct current stimulation (tsDCS); Procedure · Device · Other + 1 more
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 1,273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Metastatic Malignant Neoplasm to Brain, Recurrent Brain Metastases, Progressive Brain Metastases
Interventions: Palbociclib, Pembrolizumab; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Concussion, mTBI, Post-Concussive Symptoms, Chronic Headache, Chronic Insomnia, Chronic Attention Disorder
Interventions: Neurofeedback (NFB); Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Breast Cancer-related Subclinical Lymphedema
Interventions: 20-30 mmHg compression sleeve and gauntlet, Manual Lymphatic Drainage; Other
Lead sponsor: Mercy Research; Other
Eligibility: 18 Years and older · Female only
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Retroperitoneal Sarcoma, Liposarcoma, Dedifferentiated Liposarcoma
Interventions: Abemaciclib, Computed Tomography, Magnetic Resonance Imaging, Radiation Therapy, Therapeutic Surgical Procedure; Drug · Procedure · Radiation
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Adult
Interventions: Motor Sequence Task; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years to 40 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Vitamin B6 Deficiency
Interventions: Arm 1 glycine and leucine, Arm 2 Intervention of Serine and methionine infusion; Dietary Supplement
Lead sponsor: University of Florida; Other
Eligibility: 20 Years to 40 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Colorectal Cancer, Cancer, Rectum Cancer, Colon Cancer
Interventions: mPATH-CRC, mPATH-Checkin, "high touch" Implementation strategy, "low touch" Implementation Strategy; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 77,145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Polycystic Ovary Syndrome
Interventions: Metformin; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Anxiety, Wellness, Psychological
Interventions: Community-based recreation program referral, Pre-surveys only; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: Miami, Florida • Durham, North Carolina

Conditions: Colorectal Cancer, Health Literacy
Interventions: CHOICE decision aid, YourMeds patient education program; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 50 Years to 75 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: IDH1 Mutation, Acute Myeloid Leukemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
Interventions: Ivosidenib, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 7
States / cities: Atlanta, Georgia • Kansas City, Kansas • Boston, Massachusetts + 3 more

Search by objective public record fields.

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4

Evaluation of a New Training Model for Ultrasound Guided Regional Anesthesia - A Feasibility Study

Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation

Fractional CO2 Laser System (Fraxel Repair Laser) Intended for Treatment of Perioral Rhytides/Wrinkles

Fat Grafting for Pedal Fat Pad Atrophy

A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach

Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease

Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy

The Utility of Timed Segmental Withdrawal During Screening Colonoscopy

Physiological Investigations of Movement Disorders

Palbociclib and Pembrolizumab In Central Nervous System Metastases

Neurofeedback Impact on Veterans With mTBI

Subclinical Lymphedema Treatment Study

A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas

Effects of Feedback on Learning of a Motor Sequence Task

Vitamin B6 Dependence of One-Carbon Metabolism

Effectiveness and Implementation of mPATH-CRC

Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome

You & Me Healthy: Youth Empowered Self-Care Substudy (YES)

Effectiveness Study of a Computer-Based Colorectal Cancer Screening Decision Aid

Ivosidenib as Post-HSCT Maintenance for AML